Lindis Blood Care successfully closes follow-on financing round
Novel approach designed to be a safe and cost-effective way to reliably remove tumor cells from autologous blood
14-Feb-2022 -
Lindis Blood Care, a company aiming to set a new Gold Standard for blood management during cancer surgeries with its medical device CATUVAB®, announced the closing of a follow-on financing round. The new investment will mainly be used to expand the clinical program, take the company through the ...
blood
blood transfusions
financing
+1